Tapewire

Nasdaq · USD

ARDX

ARDELYX, INC.

Export transactions ↓
Tapewire entity
4972
SEC CIK
0001437402
Parsed reports
540

Last 12 months

Inside the activity.

1 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202601
Feb 2026125
Mar 202601
Apr 202601
May 2026020
Jun 202602
Jul 202601
Aug 2026021
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 21, 2026 Filed Aug 25, 2026 23:17 UTC SaleCommon Stock 1,110 $3.86 $4,281.16
Disclosure

SEC source: 0002044416-26-000008 · wk-form4_1787699872.xml · nonDerivative · entry 2

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,854

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:17 UTC SaleCommon Stock 2,872 $3.86 $11,077.02
Disclosure

SEC source: 0002044416-26-000008 · wk-form4_1787699872.xml · nonDerivative · entry 1

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,964

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:13 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 2,575 $3.86 $9,931.52
Disclosure

SEC source: 0002034148-26-000007 · wk-form4_1787699594.xml · nonDerivative · entry 3

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,410

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:13 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 3,389 $3.86 $13,071.03
Disclosure

SEC source: 0002034148-26-000007 · wk-form4_1787699594.xml · nonDerivative · entry 2

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 411,985

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:13 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 2,598 $3.86 $10,020.23
Disclosure

SEC source: 0002034148-26-000007 · wk-form4_1787699594.xml · nonDerivative · entry 1

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 415,374

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:09 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 1,734 $3.86 $6,687.86
Disclosure

SEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 4

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,456

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:09 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 2,430 $3.86 $9,372.27
Disclosure

SEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 3

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,190

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:09 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 3,089 $3.86 $11,913.96
Disclosure

SEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 2

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,620

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:09 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 3,486 $3.86 $13,445.15
Disclosure

SEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,709

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:19 UTC
Hohenleitner SusanChief Financial Officer
SaleCommon Stock 1,558 $3.86 $6,009.05
Disclosure

SEC source: 0002093095-26-000007 · wk-form4_1787699976.xml · nonDerivative · entry 1

Hohenleitner Susan · CIK 0002093095 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,520

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:16 UTC
Bishop John ESee Remarks
SaleCommon Stock 2,469 $3.86 $9,522.69
Disclosure

SEC source: 0001308911-26-000007 · wk-form4_1787699798.xml · nonDerivative · entry 2

Bishop John E · CIK 0001308911 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,095

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:16 UTC
Bishop John ESee Remarks
SaleCommon Stock 17,281 $3.86 $66,651.09
Disclosure

SEC source: 0001308911-26-000007 · wk-form4_1787699798.xml · nonDerivative · entry 1

Bishop John E · CIK 0001308911 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,564

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:15 UTC
Brady James ParkerChief Human Resources Officer
SaleCommon Stock 13,160 $3.86 $50,756.80
Disclosure

SEC source: 0002088887-26-000007 · wk-form4_1787699714.xml · nonDerivative · entry 2

Brady James Parker · CIK 0002088887 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,930

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:15 UTC
Brady James ParkerChief Human Resources Officer
SaleCommon Stock 1,976 $3.86 $7,621.23
Disclosure

SEC source: 0002088887-26-000007 · wk-form4_1787699714.xml · nonDerivative · entry 1

Brady James Parker · CIK 0002088887 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,090

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:11 UTC
Kelliher MikeChief Business Officer
SaleCommon Stock 2,002 $3.86 $7,721.51
Disclosure

SEC source: 0001987188-26-000009 · wk-form4_1787699487.xml · nonDerivative · entry 3

Kelliher Mike · CIK 0001987188 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,660

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:11 UTC
Kelliher MikeChief Business Officer
SaleCommon Stock 2,652 $3.86 $10,228.50
Disclosure

SEC source: 0001987188-26-000009 · wk-form4_1787699487.xml · nonDerivative · entry 2

Kelliher Mike · CIK 0001987188 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,662

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:11 UTC
Kelliher MikeChief Business Officer
SaleCommon Stock 3,104 $3.86 $11,971.82
Disclosure

SEC source: 0001987188-26-000009 · wk-form4_1787699487.xml · nonDerivative · entry 1

Kelliher Mike · CIK 0001987188 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354,314

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:07 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 19,178 $3.86 $73,967.63
Disclosure

SEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 4

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,619,792

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:07 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 8,411 $3.86 $32,440.39
Disclosure

SEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 3

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,638,970

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:07 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 15,976 $3.86 $61,617.83
Disclosure

SEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,647,381

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 23:07 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 15,009 $3.86 $57,888.21
Disclosure

SEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,663,357

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 20:09 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 20,834 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001321402-26-000016 · wk-form4_1784318944.xml · derivative · entry 5

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 290,834

Underlying: Common Stock · 20,834 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 20:09 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 41,668 $5.06 $210,923.42
Disclosure

SEC source: 0001321402-26-000016 · wk-form4_1784318944.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,678,366

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.03 to $5.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 17, 2026 20:09 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionCommon Stock 20,834 $0.99 $20,625.66
Disclosure

SEC source: 0001321402-26-000016 · wk-form4_1784318944.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,720,034

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:01 UTC
Williams Laura AChief Patient Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 31,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001869194-26-000008 · wk-form4_1782158491.xml · derivative · entry 3

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.

F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:01 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 81,898 $5.99 $490,487.12
Disclosure

SEC source: 0001869194-26-000008 · wk-form4_1782158491.xml · nonDerivative · entry 2

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 378,195

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.97 to $6.0086, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:01 UTC
Williams Laura AChief Patient Officer
Exercise / conversionCommon Stock 31,000 $0.99 $30,690.00
Disclosure

SEC source: 0001869194-26-000008 · wk-form4_1782158491.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 460,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:05 UTC GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001799355-26-000006 · wk-form4_1781813140.xml · derivative · entry 2

Cadoret-Manier Onaiza · CIK 0001799355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:05 UTC GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001799355-26-000006 · wk-form4_1781813140.xml · nonDerivative · entry 1

Cadoret-Manier Onaiza · CIK 0001799355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,156

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:14 UTC GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001792150-26-000002 · wk-form4_1781817269.xml · derivative · entry 2

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:14 UTC GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001792150-26-000002 · wk-form4_1781817269.xml · nonDerivative · entry 1

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,746

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:08 UTC GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001313397-26-000002 · wk-form4_1781813313.xml · derivative · entry 2

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:08 UTC GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001313397-26-000002 · wk-form4_1781813313.xml · nonDerivative · entry 1

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 439,998

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:07 UTC
MOTT DAVID MDirector
GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001219871-26-000003 · wk-form4_1781813248.xml · derivative · entry 3

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F4 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F5 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:07 UTC
MOTT DAVID MDirector
GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001219871-26-000003 · wk-form4_1781813248.xml · nonDerivative · entry 2

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,349,655

F3 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:07 UTC
MOTT DAVID MDirector
GrantCommon Stock 20,282 $0.00 $0.00
Disclosure

SEC source: 0001219871-26-000003 · wk-form4_1781813248.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,323,200

F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.

F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:04 UTC
Bhanji MunaDirector
GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001846905-26-000004 · wk-form4_1781813041.xml · derivative · entry 2

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:04 UTC
Bhanji MunaDirector
GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001846905-26-000004 · wk-form4_1781813041.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,808

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:02 UTC GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001291937-26-000003 · wk-form4_1781812963.xml · derivative · entry 3

Bertrand William C JR · CIK 0001291937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F3 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F4 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:02 UTC GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001291937-26-000003 · wk-form4_1781812963.xml · nonDerivative · entry 2

Bertrand William C JR · CIK 0001291937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,507

F2 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:02 UTC GrantCommon Stock 12,345 $0.00 $0.00
Disclosure

SEC source: 0001291937-26-000003 · wk-form4_1781812963.xml · nonDerivative · entry 1

Bertrand William C JR · CIK 0001291937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,052

F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:01 UTC GrantStock Option (Right to Buy) · Derivative 39,715 $0.00 Strike: $5.67 $0.00
Disclosure

SEC source: 0001620152-26-000005 · wk-form4_1781812867.xml · derivative · entry 2

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,715

Underlying: Common Stock · 39,715 shares

Expires 2036-06-16

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:01 UTC GrantCommon Stock 26,455 $0.00 $0.00
Disclosure

SEC source: 0001620152-26-000005 · wk-form4_1781812867.xml · nonDerivative · entry 1

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,006

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:01 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 20,833 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001321402-26-000014 · wk-form4_1781726515.xml · derivative · entry 5

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 311,668

Underlying: Common Stock · 20,833 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:01 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 41,666 $5.67 $236,346.22
Disclosure

SEC source: 0001321402-26-000014 · wk-form4_1781726515.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,699,200

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.625 to $5.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:01 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionCommon Stock 20,833 $0.99 $20,624.67
Disclosure

SEC source: 0001321402-26-000014 · wk-form4_1781726515.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,740,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:18 UTC SaleCommon Stock 1,036 $6.27 $6,493.13
Disclosure

SEC source: 0002044416-26-000005 · wk-form4_1779481118.xml · nonDerivative · entry 2

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,836

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Includes 1,765 shares acquired under the Issuer's employee stock purchase plan on February 27, 2026.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:18 UTC SaleCommon Stock 2,683 $6.27 $16,815.70
Disclosure

SEC source: 0002044416-26-000005 · wk-form4_1779481118.xml · nonDerivative · entry 1

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,107

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:12 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 2,405 $6.27 $15,073.34
Disclosure

SEC source: 0002034148-26-000004 · wk-form4_1779480738.xml · nonDerivative · entry 3

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,972

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:12 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 2,427 $6.27 $15,211.22
Disclosure

SEC source: 0002034148-26-000004 · wk-form4_1779480738.xml · nonDerivative · entry 2

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,377

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.